Sign in

NCT03506451Completed

PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study

Source: ClinicalTrials.gov · Last updated 5 Oct 2026

Brief summary (registry, in English)

The purpose of this single institution, pilot study is to explore the out of pocket (OOP)costs and financial toxicity of cancer care for patients during definitive treatment of head and neck cancer with radiation therapy with or without chemotherapy and surgical resection. The study team will assess how the financial burden of cancer care impacts quality of life as well as treatment-related decision-making from a patient perspective.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
20 Apr 2018
Start date
19 Jun 2018
Primary completion date
29 Nov 2021
Lead sponsor
Duke University
NCT number
NCT03506451

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 19 Jun 2018 to the primary completion date, 29 Nov 2021
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior radiation courses must be approved by PI prior to approaching patient for enrollment (prior systemic therapy is not an exclusion to study enrollment).

Other illness

  • Recurrent disease
  • Metastatic disease

Who the study is looking for

  • Adult (18 years or older) patients
  • Diagnosed with HNC with treatment plan including definitive radiation therapy or chemotherapy/radiation therapy
  • Be able to read and write in English
  • Able to give informed consent and complete survey materials

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duke Cancer Center
Coordinator of this site? Confirm its status
DurhamUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.